Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
IR-Med (IRME) just unveiled an update.
IR-Med, Inc. has named Ran Ziskind as the new CEO, effective September 1, 2024. Ziskind, who has a notable background as the co-founder and CEO of Galatea Ltd., brings extensive experience in spearheading technology innovations and managing global crises. His appointment includes an employment agreement offering a salary tied to company funding milestones, car expenses, and a stock option plan, all designed to align his interests with the company’s success. No conflicts of interest were reported in relation to his appointment.
Learn more about IRME stock on TipRanks’ Stock Analysis page.
